ResMed (RMD)

EBITDA Margin

38.33%

TTM · Period ending:

RMD logo

RMD EBITDA Margin

Latest reported38.33%
RMD TTM EBITDA Margin (9.09% → 38.33%)
High-resolution chart · PNG

RMD ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

ResMed EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
31.2079%
35.1015%
33.9746%
34.4367%
34.0546%
34.4381%
34.686%
34.0451%
33.7472%
33.6957%
33.0739%
33.1939%
31.5789%
29.2484%
26.8551%
23.6084%
21.9512%
20.0873%
17.7986%
33.3333%
51.1561%
6.1889%
23.0483%
15.8537%
11.9149%
37.6238%
30.3867%
21.25%
9.3525%
44%
35.7798%
24.7312%
9.0909%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.